PlainPharmaWatch

CMS Open Payments · Program Year 2024

Pulse Biosciences, Inc.

Pulse Biosciences, Inc. reported $534,821.47 in payments to 72 physicians and teaching hospitals across 72 transactions.

See the rankings → How this is sourced
$534.8K
Total payments
72
Transactions
72
Recipients
#745
of 1,925 companies

Pulse Biosciences, Inc. reported $534,821.47 in payments to 72 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #745 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $7.4K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Pulse Biosciences, Inc. pairs above-median payment volume with a moderately concentrated payment pattern.

#745
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
4
payment categories

How Pulse Biosciences, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Pulse Biosciences, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$534,821 Top 39% higher than 61% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Pulse Biosciences, Inc.

$534,821.47: that is what Pulse Biosciences, Inc. reported in payments to 72 physicians and teaching hospitals during Program Year 2024, spread across 72 transactions ($7.4K per transaction, $7.4K per recipient). The company sits at rank #745 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 4-category general-payment breakdown below at $377.2K (70.5% of the company's reported total, 38 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Pulse Biosciences, Inc.'s 4-category general-payment breakdown at $377.2K, 70.5% of the reported total.

How Pulse Biosciences, Inc. divides its payments

How the reported total splits across payment categories

1. Consulting Fee$377.2K2. Long-Term Medical Supply …$115.0K3. Travel and Lodging$40.7K4. Food and Beverage$2.0K
Payment Type Amount Transactions
Consulting Fee $377.2K 38
Long-Term Medical Supply or Device Loan $115.0K 16
Travel and Lodging $40.7K 4
Food and Beverage $2.0K 14

Recipient Concentration in General Payments

The five largest recipient relationships account for $449,325.50 (84.0%) of $534,821.47 in this company's General Payments records across 19 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Pulse Biosciences, Inc.

The five named recipients with the highest reported General Payments from this company

Gansevoort Hurlbut Dunningti…$137.1KNiv Ad$130.9KDavid Noah Kenigsberg$81.0KRalph P. Tufano$71.2KRichard J Harding$29.2K
  1. 1

    Gansevoort Hurlbut Dunningtion

    $137,102.67 across 12 reported transactions

  2. 2

    Niv Ad

    $130,891.53 across 10 reported transactions

  3. 3

    David Noah Kenigsberg

    $80,977.20 across 6 reported transactions

  4. 4

    Ralph P. Tufano

    $71,177.05 across 11 reported transactions

  5. 5

    Richard J Harding

    $29,177.05 across 5 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $7.4K. Average per recipient: $7.4K.

Total Amount

$534,821.47

Avg per Transaction

$7.4K

Avg per Recipient

$7.4K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Pulse Biosciences, Inc. Share

0.0%

#745 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Pulse Biosciences, Inc.

OraPharma, a division of Bausch Health US, LLC

$539.1K 7,610 recipients

Dynavax Technologies Corporation

$530.5K 5,747 recipients

OraSure Technologies Inc.

$529.4K 45 recipients

Veryan Medical Incorporated

$525.9K 278 recipients

GC America Inc.

$524.2K 2,479 recipients

Zynex Monitoring Solutions

$546.3K 0 recipients

Frequently Asked Questions

How much did Pulse Biosciences, Inc. pay to physicians and hospitals in 2024? ▾
Pulse Biosciences, Inc. made $534,821.47 in payments to physicians and hospitals in Program Year 2024, across 72 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Pulse Biosciences, Inc.? ▾
Averaging $7.4K per recipient, Pulse Biosciences, Inc.'s 2024 payments reached 72 physicians and teaching hospitals.
What types of payments did Pulse Biosciences, Inc. make? ▾
General payments from Pulse Biosciences, Inc. span 4 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $377.2K, representing 70.5% of the company's reported total.
How does Pulse Biosciences, Inc. rank among pharmaceutical companies? ▾
Pulse Biosciences, Inc. ranks #745 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Pulse Biosciences, Inc.? ▾
In 2024, Pulse Biosciences, Inc. averaged $7.4K per transaction across 72 transactions to 72 recipients.
Where does the payment data for Pulse Biosciences, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Pulse Biosciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.